Ching-Lan Lu Instructor in Medicine

Publications

Sort by

Co-Author Network

Combination therapy with anti-HIV-1 antibodies maintains viral suppression. Nature. 2018 Academic Article GET IT
Times cited: 395
Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117. The Journal of experimental medicine. 2018 Academic Article GET IT
Times cited: 90
Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo. Cell. 2017 Academic Article GET IT
Times cited: 117
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption. Nature. 2016 Academic Article GET IT
Times cited: 394
Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo. Science (New York, N.Y.). 2016 Academic Article GET IT
Times cited: 299
Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice. Cell. 2014 Academic Article GET IT
Times cited: 331

Sort by

Co-investigator Network

Defining novel neuro-immune pathways that regulate gut physiology awarded by National Institute of Diabetes & Digestive & Kidney Diseases Principal Investigator 2025 - 2030